CB44443-22 - 0x00000000000064F2

Males & Females of Non-Childbearing Potential

Gateway

* Stipend may pay up to reflected amount.
Start Date: 
January 8, 2026 - 2:00pm
End Date: 
January 27, 2026 - 9:00am

Study Details

Study Number: CB44443
Group Number: 22
Study Requirement: Healthy Normal Male and Female
Stipend: up to $10,000.00

Study Criteria

Age: 19 - 55
BMI: 18 - 32
Weight Restriction: minimum weight 111 lbs

Study Information

Indication: This investigational medication is being developed to help treat Tuberculosis.
Route of Administration: Oral
Blood Draws: 37

Study Schedule

Schedule Type: Long Term
Study Length: 19 Night Stay

Screening Dates:

Event Day Event Date
Friday 12/19/2025
Tuesday 12/30/2025
Wednesday 12/31/2025
Friday 1/2/2026
Wednesday 1/7/2026

Doctor Exam Dates:

Event Day Event Date
Friday 12/19/2025
Tuesday 12/30/2025
Wednesday 12/31/2025
Friday 1/2/2026
Wednesday 1/7/2026

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Thursday 1/8/2026 2:00:00 PM Tuesday 1/27/2026 9:00:00 AM 1 Lincoln